Bluejay Diagnostics (BJDX) Income from Continuing Operations (2020 - 2026)
Bluejay Diagnostics recorded quarterly Income from Continuing Operations of 1919972.0 in Q1 2026, down 34.23% quarter-over-quarter from 1430391.0 in Q4 2025, and down 2.61% year-over-year from 1971447.72 in Q1 2025.
Bluejay Diagnostics' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 1919972.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 2.61% year-over-year to 1919972.0; the TTM figure through Mar 2026 stood at 6904878.0 (up 5.6% YoY), while the FY2025 annual figure was 6856252.0, up 12.62% from the prior year.
- Income from Continuing Operations came in at 1919972.0 for Q1 2026 at Bluejay Diagnostics, down from 1430391.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1430391.0 in Q4 2025 to a low of 2903688.0 in Q2 2023.
- A 5-year average of 2132152.41 and a median of 2068261.0 in 2022 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations plunged 786.91% in 2022 and jumped 39.38% in 2024, its largest moves.
- Bluejay Diagnostics' Income from Continuing Operations stood at 2453612.0 in 2022, then advanced by 2.73% to 2386724.0 in 2023, then surged by 39.38% to 1446741.0 in 2024, then grew by 1.13% to 1430391.0 in 2025, then sank by 34.23% to 1919972.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 1919972.0, 1430391.0, and 1598186.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | -1.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.92 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.96 Mn |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -1.49 Mn |
| Jun 30, 2024 | -2.51 Mn |
| Mar 31, 2024 | -2.40 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -2.34 Mn |
| Jun 30, 2023 | -2.90 Mn |
| Mar 31, 2023 | -2.68 Mn |
| Dec 31, 2022 | -2.45 Mn |
| Sep 30, 2022 | -2.81 Mn |
| Jun 30, 2022 | -1.99 Mn |
| Mar 31, 2022 | -2.07 Mn |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | -957,988.00 |
| Jun 30, 2021 | -666,072.00 |
| Mar 31, 2021 | -233,198.00 |
| Dec 31, 2020 | -581,779.00 |
| Sep 30, 2020 | -148,169.00 |